Earnings - 6th April 2009

4:03PM Immucor beats by $0.05, beats on revs; guides FY09 EPS above consensus, reaffirms FY09 revs guidance (BLUD) 24.06 -0.48 : Reports Q3 (Feb) earnings of $0.27 per share, $0.05 better than the First Call consensus of $0.22; revenues rose 12.4% year/year to $75.3 mln vs the $73.2 mln consensus. Co issues guidance for FY09, sees EPS at or modestly above $1.02 vs. $0.99 consensus; sees FY09 revs of $292-300 mln vs. $297.01 mln consensus.